Private company

Black Bird Biotech, Inc.

Black Bird Biotech, Inc. is an American miscellaneous manufacturing industries company, incorporated in Nevada.¹ It is headquartered in Argyle, Texas.¹

Last updated Oct 21, 2026.

Overview

IndustryMiscellaneous Manufacturing Industries¹
HeadquartersArgyle, Texas¹
Incorporated inNV²
Business address11961 Hilltop Road, Suite 22, Argyle, Tx 76226²
Filer category, Emerging growth company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

40.0%Gross margin³

-1560.4%Operating margin³

-2009.1%Net margin³

-21.0%Revenue growth, 2022³

Where the money goes

Where each dollar of revenue went, fiscal 2022

Cost of revenueInterest

Cost of revenue12¢$49.6K
Interest88¢$370.6K

Out of $82.6K in revenue.³ The company lost money this year.

Financial statements

Revenue⁴⁵³$82.6K in 2022+365% since 2019

Gross profit⁴⁵³$33.0K in 2022

Operating income⁶⁷⁸⁴⁵³-$1.3M in 2022+1601% since 2016

Net income⁶⁷⁸⁴⁵³-$1.7M in 2022+1461% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Revenue				$17.8K⁴	$57.6K⁵	$104.5K³	$82.6K³
Cost of revenue				$17.8K⁴	$28.2K⁵	$84.9K³	$49.6K³
Gross profit				-$31⁴	$29.4K⁵	$19.6K³	$33.0K³
Operating expenses						$1.5M³	$1.3M³
Operating income	-$75.7K⁶	-$76.2K⁷	-$83.5K⁸	-$149.7K⁴	-$684.8K⁵	-$1.5M³	-$1.3M³
Interest	$30.5K⁶	$33.8K⁷	$37.6K⁸	$0⁴	$5.9K⁵	$285.3K³	$370.6K³
Income before tax						-$1.8M³	-$1.7M³
Income tax				$0⁴	$0⁵	$0³	$0³
Net income	-$106.3K⁶	-$110.0K⁷	-$121.1K⁸	-$149.4K⁴	-$690.2K⁵	-$1.8M³	-$1.7M³
Earnings per share				$0.00⁴	$0.00⁵	$0.00³	$0.00³
Earnings per share (diluted)				$0.00⁴	$0.00⁵	$0.00³	$0.00³
Shares (weighted, basic)						194.4M shares³	330.7M shares³
Shares (weighted, diluted)						225.5M shares³	806.4M shares³

Total assets⁶⁷⁸⁴⁵³$218.5K in 2022+1406% since 2016

Total liabilities⁶⁷⁸⁴⁵³$868.7K in 2022+8% since 2016

Shareholders’ equity⁷⁸⁴⁵³-$650.2K in 2022−17% since 2016

Cash⁶⁷⁴⁵³$44.4K in 2022

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Cash	$0⁶	$0⁷	$37.7K⁴	$86.0K⁵	$53.0K⁵	$499.8K³	$44.4K³
Receivables						$2.7K³	$2.3K³
Inventory						$74.5K³	$88.4K³
Current assets				$973⁴	$106.2K⁵	$678.2K³	$135.1K³
Intangible assets						$190.0K⁵	$190.0K³
Total assets	$14.5K⁶	$1.6K⁷	$4.7K⁸	$973⁴	$126.2K⁵	$774.2K³	$218.5K³
Current liabilities				$1.1M⁴	$98.5K⁵	$104.0K³	$868.7K³
Total liabilities	$802.2K⁶	$899.3K⁷	$1.0M⁸	$1.1M⁴	$98.5K⁵	$104.0K³	$868.7K³
Retained earnings						-$2.6M³	-$4.3M³
Shareholders’ equity	-$787.7K⁷	-$897.7K⁸	-$1.0M⁴	-$1.1M⁵	$27.6K³	$670.2K³	-$650.2K³
Shares outstanding	86.0M shares⁶	86.0M shares⁷	86.0M shares⁸	86.0M shares⁴	164.9M shares⁵	301.2M shares³	310.7M shares³

Cash from operations⁶⁷⁸⁴⁵³-$1.0M in 2022+1225% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Cash from operations	-$77.9K⁶	-$75.7K⁷	-$76.1K⁸	-$131.1K⁴	-$619.5K⁵	-$992.4K³	-$1.0M³
Depreciation and amortization						$109.7K³	$88.9K³
Cash from investing						-$185.7K³	$0³
Cash from financing						$1.6M³	$577.3K³

Compare Black Bird Biotech, Inc. with another company

What it owns

What Black Bird Biotech, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Furniture and fixtures	$7.1K³ Dec 31, 2022	$11.6K³ Dec 31, 2021	−38.6%

Intangibles and goodwill

Item	Latest	A year before	Change
Intangible assets, net (excluding goodwill)	$190.0K³ Dec 31, 2022	$190.0K⁵ Dec 31, 2021	0%
Finite-lived intangibles, net	$84.4K³ Dec 31, 2021	$0⁵ Dec 31, 2020

Inventory

Item	Latest	A year before	Change
Inventory, total	$88.4K³ Dec 31, 2022	$74.5K³ Dec 31, 2021	+18.7%
Raw materials	$28.3K³ Dec 31, 2022	$23.6K⁵ Dec 31, 2021	+20.1%
Work in process	$60.1K³ Dec 31, 2022	$50.9K⁵ Dec 31, 2021	+18.0%

Leadership

Who has led Black Bird Biotech, Inc., and when. Pick a name to see everywhere that person has worked.

2010201520202025

Chief executive officerRobert Edward Shea Sep 30, 2008 to Sep 30, 2008¹¹
PresidentRobert Edward Shea Sep 30, 2008 to Sep 30, 2008¹¹
Chief financial officerRobert Edward Shea Sep 30, 2008 to Sep 30, 2008¹¹

Board members and other officers (1)

Board memberRobert Edward Shea Sep 30, 2008 to Sep 30, 2008¹¹

Former names

Digital Development Partners, Inc.Oct 16, 2009 to Jun 21, 2021²
Cyprium Resources Inc.Sep 10, 2007 to Aug 12, 2009²

Timeline

Mar 5, 20248-K Change in control; Executive or director change¹²
Dec 22, 20238-K Change of auditor¹³
Dec 21, 20228-K Entered a material agreement; Listing notice or transfer¹⁴
Aug 15, 20228-K Entered a material agreement; Bylaws or fiscal year changed; Regulation FD disclosure¹⁵
May 23, 20228-K Entered a material agreement; New debt or obligation¹⁶
May 10, 20228-K Entered a material agreement; New debt or obligation¹⁷
Apr 26, 20228-K Bylaws or fiscal year changed¹⁸
Apr 12, 20228-K Entered a material agreement; Executive or director change¹⁹
Mar 22, 20228-K Entered a material agreement²⁰
Sep 30, 2008New chief executive Robert Edward Shea becomes CEO¹¹

Filings

43 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 9 major events, 25 other. The latest 20:

The 43 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Black Bird Biotech, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARBlack Bird Biotech, Inc.¹
CIK0001409999
Employer ID (EIN)98-0521119¹
Filer status<br>emerging growth company¹
Incorporated inNevada¹
Fiscal year endsDecember 31¹
Industry code (SIC)3990 Miscellaneous Manufacturing Industries¹
SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance¹
Business address11961 Hilltop Road, Suite 22, Argyle, TX 76226¹
Phone833-223-4204¹
Shares outstanding0 as of Nov 20, 2023¹⁰
Public float$3.3M as of Jun 30, 2022³
On EDGAR sinceSep 10, 2007¹
Filings214 in all: 10-Q (48), 8-K (34), NT 10-Q (20), UPLOAD (17), 10-K (15), CORRESP (12), NT 10-K (10), 8-K/A (6)¹
All 33 form types
PRE 14C (6), 1-A POS (5), DEF 14C (5), 10-Q/A (4), QUALIF (4), 253G1 (3), 3 (3), 1-A (2), 253G2 (2), EFFECT (2), SC 14F1 (2), 1-A/A (1), 1-Z (1), 10-K/A (1), 10KSB (1), 10QSB (1), 4 (1), 4/A (1), 424B3 (1), 8-A12G (1), D (1), PRER14C (1), S-1 (1), S-1/A (1), SB-2 (1)
Latest filingsAnnual report (10-K) Mar 21, 2023
Quarterly report (10-Q) Nov 20, 2023
Latest 8-K (8-K) Mar 5, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBlack Bird Biotech, Inc. filings on SEC EDGAR
2
SEC EDGARBlack Bird Biotech, Inc. filings on SEC EDGAR
3
SEC EDGARBlack Bird Biotech, Inc. 10-K for fiscal 2022
4
SEC EDGARBlack Bird Biotech, Inc. 10-K for fiscal 2019
5
SEC EDGARBlack Bird Biotech, Inc. 10-K for fiscal 2020
6
SEC EDGARBlack Bird Biotech, Inc. 10-K for fiscal 2016
7
SEC EDGARBlack Bird Biotech, Inc. 10-K for fiscal 2017
8
SEC EDGARBlack Bird Biotech, Inc. 10-K for fiscal 2018
9
SEC EDGARBlack Bird Biotech, Inc. 10-Q for fiscal 2023
10
SEC EDGARBlack Bird Biotech, Inc. 10-Q for fiscal 2023
11
SEC EDGARRobert Edward Shea, Chief executive officer
12
SEC EDGARChange in control; Executive or director change
13
SEC EDGARChange of auditor
14
SEC EDGAREntered a material agreement; Listing notice or transfer
15
SEC EDGAREntered a material agreement; Bylaws or fiscal year changed; Regulation FD disclosure
16
SEC EDGAREntered a material agreement; New debt or obligation
17
SEC EDGAREntered a material agreement; New debt or obligation
18
SEC EDGARBylaws or fiscal year changed
19
SEC EDGAREntered a material agreement; Executive or director change
20
SEC EDGAREntered a material agreement